PioneerGenomic is a sub-category of knowledge-based companies that, with the cooperation of a team of the best specialists, has taken steps towards localization and scientific, technological, and commercial advancement and has made unparalleled progress in the fields of bioinformatics, artificial intelligence, biotechnology, and gene therapy. , stem cells, genomics, biotechnology and personalized medicine and cancer. This company was established with the aim of producing knowledge and providing genetic testing services according to the most up-to-date methods in the world (third generation sequencing) and setting up a genetic scientific-research center (R&D)
OncoExact involves the analysis of a wide range of cancer biomarkers to provide insights into the molecular characteristics of a patient's tumor. OncoExact's goal is to help oncologists and healthcare providers identify the most appropriate therapeutic options for each patient, increasing the chances of successful treatment outcomes and minimizing the potential for ineffective treatments.
The referring person is referred for the exomin test when he has clinical symptoms suspected of genetic disorders. After obtaining the comprehensive DNA information of the referring person, bioinformatics, artificial intelligence and medical genetics experts will finally identify the desired change by carefully analyzing this information and according to the inheritance pattern of the possible genetic disease. The accurate identification of the genetic changes that cause the disease (single nucleotide changes, deletions and additions) of the referring person makes it possible to ensure whether the fetus is healthy or sick by examining these changes in subsequent pregnancies, and also to provide the best possible prevention and treatment options to the patients. presented
